Abstract
Background
Heart failure with reduced ejection fraction (HFrEF) is characterized by activation of the sympathetic nervous system and increased arterial stiffness, leading to an impaired ventricular-vascular coupling. Baroreflex activation therapy (BAT) has been shown to reduce muscle sympathetic nerve activity (MSNA) and improve clinical status of patients with HFrEF. The purpose of this investigation was to determine the effects of BAT on arterial stiffness in HFrEF.
Methods and results
MSNA, clinical variables, and parameters of central blood pressure (BP) and arterial stiffness were collected in 18 NYHA Class III HFrEF patients, nine receiving BAT and nine continuing with optimal medical management alone. Patients were followed for 3 months, with measurements at that time compared to baseline evaluation. Baseline characteristics of the groups were well matched. At 3 months, BAT did not improve central BP and arterial stiffness despite a significant amelioration of MSNA, NYHA class, Minnesota living with heart failure questionnaire score, number of heart failure medications and six-minute walking distance. The control group exhibited no significant changes in all the measured variables.
Conclusions
Despite significant reductions in MSNA and clinical improvement, BAT does not appear to chronically modify arterial stiffness within this HFrEF cohort. Additional study is required to determine if this result applies to the HFrEF population as a whole.
Similar content being viewed by others
References
Braunwald E (2013) Heart Failure. J Am Coll Cardiol Heart Fail 1:1–20
Marti CN, Gheroghiade M, Kalogeropoulos AP, Georgiopoulou VV, Quyyumi AA, Butler J (2012) Endothelial dysfunction, arterial stiffness, and heart failure. J Am Coll Cardiol 60:1455–1469
Duprez DA (2012) Arterial stiffness/elasticity in the contribution to progression of heart failure. Heart Fail Clin 8:135–141
Shah AM, Mann DL (2011) In search of new therapeutic targets and strategies for heart failure. Recent advances in basic science. Lancet 378:704–712
Asanoi H, Sasayama S, Kameyama T (1989) Ventriculoarterial coupling in normal and failing heart in humans. Circ Res 65:483–493
Mitchell GF, Tardif JC, Arnold JM, Marchiori G, O’Brien TX, Dunlap ME, Pfeffer MA (2001) Pulsatile hemodynamics in congestive heart failure. Hypertension 38:1433–1439
Florea VG, Cohn JN (2014) The autonomic nervous system and heart failure. Circ Res 114:1815–1826
Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, Simon AB, Rector T (1984) Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 311:819–823
Benedict CR, Johnstone DE, Weiner DH, Bourassa MG, Bittner V, Kay R, Kirlin P, Greenberg B, Kohn RM, Nicklas JM (1994) Relation of neurohumoral activation to clinical variables and degree of ventricular dysfunction: a report from the registry of studies of left ventricular dysfunction. SOLVD Investigators. J Am Coll Cardiol 23:1410–1420
Hasking GJ, Esler MD, Jennings GL, Burton D, Johns JA, Korner PI (1986) Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation 73:615–621
Grassi G, Seravalle G, Cattaneo BM, Lanfranchi A, Vailati S, Giannattasio C, Del Bo A, Sala C, Bolla G, Pozzi M, Mancia G (1995) Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure. Circulation 92:3206–3211
Grassi G, Giannattasio C, Failla M, Pesenti A, Peretti G, Marinoni E, Fraschini N, Vailati S, Mancia G (1995) Sympathetic modulation of radial artery compliance in congestive heart failure. Hypertension 26:348–354
Gronda E, Seravalle G, Brambilla G, Costantino G, Casini A, Alsheraei A, Lovett EG, Mancia G, Grassi G (2014) Chronic baroreflex activation effects on sympathetic nerve traffic, baroreflex function and cardiac haemodynamics in heart failure. A proof-of-concept study. Eur J Heart Fail 16:977–983
Bonapace S, Rossi A, Cicoira M, Targher G, Valbusa F, Benetos A, Vassanelli C (2013) Increased aortic pulse wave velocity as measured by echocardiography is strongly associated with poor prognosis in patients with heart failure. J Am Soc Echocardiogr 26:714–720
Regnault V, Lagrange J, Pizard A, Safar ME, Fay R, Pitt B, Challande P, Rossignol P, Zannad F, Lacolley P (2014) Opposite predictive value of pulse pressure and aortic pulse wave velocity on heart failure with reduced left ventricular ejection fraction: insights from an eplerenone post-acute myocardial infarction heart failure efficacy and survival study (EPHESUS) substudy. Hypertension 63:105–111
Lieback A, Proff J, Wessel K, Fleck E, Götze S (2012) Remote monitoring of heart failure patients using implantable cardiac pacing devices and external sensors: results of the insight-HF study. Clin Res Cardiol 101:101–107
Demming T, Frey N, Langer C (2013) Pickering syndrome: high-risk stenting of a renal artery stenosis in a multimorbid patient presenting with progressive congestive heart failure. Clin Res Cardiol 102:615–617
Schaefer CA, Adam L, Weisser-Thomas J, Pingel S, Vogel G, Klarmann-Schulz U, Nickenig G, Pizzarro C, Skowasch D (2015) High prevalence of peripheral arterial disease in patients with obstructive sleep apnoea. Clin Res Cardiol 104:719–726
Dolliner P, Brammen L, Graf S, Huelsmann M, Stiebellehner L, Gleiss A, Steurer G (2013) Portable recording for detecting sleep disorder breathing in patients under the care of a heart failure clinic. Clin Res Cardiol 102:535–542
Laporta R, Anandam A, El-Solh AA (2012) Screening for obstructive sleep apnea in veterans with ischemic heart disease using a computer-based clinical decision-support system. Clin Res Cardiol 101:737–744
Voss F, Schueler M, Lauterbach M, Bauer A, Katus HA, Becker R (2016) Safety of symptom-limited exercise testing in a big cohort of a modern ICD population. Clin Res Cardiol 105:53–58
Salvi P, Lio G, Labat C, Ricci E, Pannier B, Benetos A (2004) Validation of a new non-invasive portable tonometer for determining arterial pressure wave and pulse wave velocity: the PulsePen device. J Hypertens 22:2285–2293
Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, Pannier B, Vlachopoulos C, Wilkinson I, Struijker-Boudier H, European Network for non-invasive investigation of large arteries (2006) Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 27:2588–2605
The Reference Values for Arterial Stiffness’ Collaboration (2010) Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: ‘establishing normal and reference values. Eur Heart J 31:2338–2350
O’Rourke MF, Pauca A, Jiang XJ (2001) Pulse wave analysis. Br J Clin Pharmacol 51:507–522
Wilkinson IB, Mohammad NH, Tyrrell S, Hall IR, Webb DJ, Paul VE, Levy T, Cockcroft JR (2002) Heart rate dependency of pulse pressure amplification and arterial stiffness. J Hypertens 15:24–30
Bakris GL, Nadim MK, Haller H, Lovett EG, Schafer JE, Bisognano JD (2012) Baroreflex activation therapy provides durable benefit in patients with resistant hypertension: results of long-term follow-up in the Rheos Pivotal Trial. J Am Soc Hypertens 6:152–158
Hoppe UC, Brandt MC, Wachter R, Beige J, Rump LC, Kroon AA, Cates AW, Lovett EG, Haller H (2012) Minimally invasive system for baroreflex activation therapy chronically lowers blood pressure with pacemaker-like safety profile: results from the Barostim neo trial. J Am Soc Hypertens 6:270–276
Wustmann K, Kucera JP, Scheffers I, Mohaupt M, Kroon AA, de Leeuw PW, Schmidli J, Allemann Y, Delacrétaz E (2009) Effects of chronic baroreceptor stimulation on the autonomic cardiovascular regulation in patients with drug-resistant arterial hypertension. Hypertension 54:530–536
Wallbach M, Lehnig LY, Schroer C, Helms HJ, Lüders S, Patschan D et al (2015) Effects of baroreflex activation therapy on arterial stiffness and central hemodynamics in patients with resistant hypertension. Hypertension 33:181–186
Berthelot E, Bihry N, Brault-Melin O, Assayag P, Cohen-Solal A, Chemla D et al (2014) Changes in ventricular-arterial coupling during decongestive therapy in acute heart failure. Eur J Clin Invest 44:982–988
Kim DB, Baek SH, Jang SW, Her SH, Shin DI, Park CS et al (2013) Improvement of arterial stiffness in the transition from acute decompensated heart failure to chronic compensated heart failure. Clin Cardiol 36:358–362
Giannattasio C, Achilli F, Failla M, Capra A, Vincenzi A, Valagussa F et al (2002) Radial, carotid and aortic distensibility in congestive heart failure: effects of high-dose angiotensin-converting enzyme inhibitor or low-dose association with angiotensin type 1 receptor blockade. J Am Coll Cardiol 39:1275–1282
Van Sloten TT, Schram MT, van den Hurk K, Dekker JM, Nijpels G, Henry RM et al (2014) Local stiffness of the carotid and femoral artery is associated with incident cardiovascular events and all-cause mortality: the Hoorn study. J Am Coll Cardiol 63:1739–1747
Vermeersch SJ, Rietzschel ER, De Buyzere ML, De Bacquer D, De Backer G, Van Bortel LM et al (2008) Age and gender related patterns in carotid-femoral PWV and carotid and femoral stiffness in a large healthy, middle-aged population. J Hypertens 26:1411–1419
Laurent S, Arcaro G, Benetos A, Lafleche A, Hoeks A, Safar M (1992) Mechanism of nitrate-induced improvement on arterial compliance depends on vascular territory. J Cardiovasc Pharmacol 19:641–649
Henry RMA, Ferreira I, Dekker JM, Nijpels G, Scheffer PG, Stehouwer CDA (2009) The metabolic syndrome in elderly individuals is associated with greater muscular, but not elastic arterial stiffness, independent of low-grade inflammation, endothelial dysfunction or insulin resistance-The Hoorn Study. J Hum Hypertens 23:718–727
Kool M, Lustermans F, Kragten H, Struijker Boudier H, Hoeks A, Reneman R, Rila H, Hoogendam I, Van Bortel LM (1995) Does lowering of cholesterol levels influence functional properties of large arteries? Eur J Clin Pharmacol 48:217–223
Van Bortel LM, Kool MJ, Struijker Boudier HA (1995) Effects of antihypertensive agents on local arterial distensibility and compliance. Hypertension 26:531–534
Wohlfahrt P, Krajčoviechová A, Seidlerová J, Mayer O, Bruthans J, Filipovsky J, Laurent S, Cifkova R (2013) Arterial stiffness parameters: how do they differ? Atherosclerosis 231:359–364
Hayashi K, Yamamoto T, Takahara A, Shirai K (2015) Clinical assessment of arterial stiffness with cardio-ankle vascular index: theory and applications. J Hypertens 33:1742–1757
Grassi G, Seravalle G, Brambilla G, Trabattoni D, Cuspidi C, Corso R, Pieruzzi F, Genovesi S, Stella A, Facchetti R, Spaziani D, Bartorelli A, Mancia G (2015) Blood pressure responses to renal denervation precede an are independent of the sympathetic and baroreflex effects. Hypertension 65:1209–1216
Brandt MC, Reda S, Mahfoud F, Lenski M, Böhm M, Hoppe UC (2012) Effects of renal sympathetic denervation on arterial stiffness and central hemodynamics in patients with resistant hypertension. J Am Coll Cardiol 60:1956–1965
Ewen S, Cremers B, Meyer MR, Donazzan L, Kindermann I, Ukena C, AG Helfer, Maurere HH, Laufs U, Grassi G, Bohm M, Mafhoud F (2015) Blood pressure changes after catheter-based renal denervation are related to reductions in total peripheral resistance. J Hypertens 33:2519–2525
Gronda E, Seravalle G, Trevano FQ, Costantino G, Casini A, Alsheraei A, Lovett EG, Vanoli E, Mancia G, Grassi G (2015) Long-term chronic baroreflex activation: persistent efficacy in patients with heart failure and reduced ejection fraction. J Hypertens 33:1704–1708
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None declared.
Funding
The study reported herein was sponsored by CVRx Inc.
Rights and permissions
About this article
Cite this article
Gronda, E., Brambilla, G., Seravalle, G. et al. Effects of chronic carotid baroreceptor activation on arterial stiffness in severe heart failure. Clin Res Cardiol 105, 838–846 (2016). https://doi.org/10.1007/s00392-016-0992-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00392-016-0992-y